… In conclusion, recent results support the use of EGFR mutations as a selection criterion
for EGFR TKIs as first-line therapy for patients with advanced NSCLC. However, …

… learning model to predict EGFR mutation status in lung adenocarcinoma using non-invasive …
from 844 lung adenocarcinoma patients with pre-operative CT images, EGFR mutation and …

… for lung cancer patients with an EGFR mutation. In this review, we describe the features
of KRAS mutations in lung cancer and contrast these with the features of EGFR mutations. …

… Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung
adenocarcinoma with EGFR mutations. J Clin Oncol 2013; 31: 3327-3334, doi: 10.1200/JCO.…

… The degree and duration of response to epidermal growth factor receptor (EGFR) inhibitors
in EGFR mutated lung cancer are heterogeneous. We hypothesized that the concurrent …

… lung adenocarcinoma harboring EGFR 19 del or L858R mutations, 532 received EGFR-TKI …
clinical outcomes of 532 lung adenocarcinoma patients harboring EGFR 19 del or L858R …

… S752 mutation (the initial EGFR mutation identified in our patient) and a second mutation in
… position 790 (T790M — the second EGFR mutation identified in our patient) were introduced …

… EGFR mutations in patients, our understanding of the biology of these … EGFR mutations is
poor compared to classical mutations. In particular, clinical data focused on these mutations is …

… lung cancer (NSCLC) and somatic activating mutations of the tyrosine kinase (TK) domain of
the epidermal growth factor receptor (EGFR… sensitivity to the reversible EGFR-TK inhibitors (-…

… , EGFR mutations of patients with lung adenocarcinoma often go … significance of EGFR
mutations in lung adenocarcinoma and … study, EGFR mutations in lung adenocarcinoma patients …